BR9710975A - Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis - Google Patents

Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis

Info

Publication number
BR9710975A
BR9710975A BR9710975-4A BR9710975A BR9710975A BR 9710975 A BR9710975 A BR 9710975A BR 9710975 A BR9710975 A BR 9710975A BR 9710975 A BR9710975 A BR 9710975A
Authority
BR
Brazil
Prior art keywords
kda
exposed surface
surface adhesion
genes
ehrlichia chaffeensis
Prior art date
Application number
BR9710975-4A
Other languages
English (en)
Inventor
David H Walker
Xue-Jie Yu
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BR9710975A publication Critical patent/BR9710975A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>"GENES DE PROTEìNA DE ADESãO DE SUPERFìCIE EXPOSTA DE 120 KDA IMUNODOMINANTE DE EHRLICHIA CHAFFEENSIS"<D>. é divulgado um gene isolado que codifica um antígeno imunodominante de 120 kDa de Ehrlichia chaffeensis. A proteína de 120 kDa é uma das proteínas imunodominantes de E. chaffeensis que estimula a produção de anticorpos específicos em humanos infectados. Também divulgada é a seq³ência de aminoácido do antígeno de 120 kDa. São divulgados processos de produção de um antígeno de 120 kDa recombinante e processos terapêuticos de uso do antígeno.
BR9710975-4A 1996-05-31 1997-05-30 Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis BR9710975A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/656,034 US6015691A (en) 1996-05-31 1996-05-31 Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis
PCT/US1997/009147 WO1997045540A1 (en) 1996-05-31 1997-05-30 Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis

Publications (1)

Publication Number Publication Date
BR9710975A true BR9710975A (pt) 2000-10-24

Family

ID=24631362

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710975-4A BR9710975A (pt) 1996-05-31 1997-05-30 Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis

Country Status (5)

Country Link
US (1) US6015691A (pt)
AU (1) AU3219497A (pt)
BR (1) BR9710975A (pt)
CA (1) CA2256532C (pt)
WO (1) WO1997045540A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049313A2 (en) 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
WO2000006744A1 (en) * 1998-07-28 2000-02-10 Aquila Biopharmaceuticals, Inc. Granulocytic ehrlichia genes and uses thereof
US6043085A (en) * 1998-08-27 2000-03-28 Research Development Foundation Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
US20020115840A1 (en) * 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
CA2700476C (en) * 2007-09-21 2017-11-28 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis variable-length pcr target
WO2009039413A2 (en) * 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (p120)
US8158370B2 (en) 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
CA3018728A1 (en) 2008-10-08 2010-04-15 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
DK2424880T3 (en) * 2009-04-28 2016-10-24 Res Dev Foundation Immunoreactive Ehrlichia p120 / p140 epitopes, and uses thereof
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225295A (en) * 1987-07-07 1991-07-26 Biotech Australia Pty Ltd Nematode antigen, its production and vaccines containing it
AU1970892A (en) * 1991-04-18 1992-11-17 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Identification of a new ehrlichia species from a patient suffering from ehrlichiosis

Also Published As

Publication number Publication date
WO1997045540A1 (en) 1997-12-04
CA2256532C (en) 2010-02-09
US6015691A (en) 2000-01-18
CA2256532A1 (en) 1997-12-04
AU3219497A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
SE0103754L (sv) Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
DE3583293D1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
FI961251A0 (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
EP2258383A3 (en) Antigenic peptides derived from telomerase
EP1009814A4 (en) TYROSINE KINASE RECEPTOR, KDR
RU95115239A (ru) Аналог эритропоэтина
BR9708401A (pt) Vetores de vìrus de para-varìola
DE69637874D1 (de) C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK1015477T3 (da) 32 humane sekreterede proteiner
DE69434413D1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
ES2110996T3 (es) Alergeno de polen de ballico.
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
BR0114977A (pt) segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos
NO980122D0 (no) Emaljematriksrelatert polypeptid
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE69634994D1 (de) Bindegewebe-wachstumsfaktor 3.
ATE512162T1 (de) Antikörper gegen das p51 protein
WO1999009177A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen

Legal Events

Date Code Title Description
PC Transfer

Free format text: RESEARCH DEVELOPMENT FOUNDATION (US)

FA10 Dismissal: dismissal - article 33 of industrial property law
HKFN Application deemed withdrawn (deleted)
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O PRESENTE EXAME ENTENDENDO QUE A MATERIA FOI EXAUSTIVAMENTE DISCUTIDA CONCLUI O EXAME DO PEDIDO EM QUESTAO PROFERINDO, DE ACORDO COM O ARTIGO 37, A DECISAO DO INDEFERIMENTO DA PRESENTE APLICACAO, UMA VEZ QUE A MESMA POR NAO CUMPRIR AS EXIGENCIAS FORMULADAS CONTINUA REIVINDICANDO MATERIA EM DESCAORDO COM O DISPOSTO NOS ARTIGOS 10 (IX), 25 E 32 DA LEI 9279/96.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.